In terms of intensity, membranous, cytoplasmic, and nucleus expressions of DNM2 were recognized in 182 (87.1%), 207 (99.0%), and 27 (12.9%) bladder cancer cases, respectively (Table 2). Here, DNM2 is linked to urinary bladder cancer.